In-Vitro Fertilization Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technique (ICSI IVF, Non-ICSI/ Traditional IVF), By Product (IVF Culture Media, ICSI Machine, IVF Incubators, Cryo-System, Others), By Egg Donor (Frozen Non-donor, Fresh Non-donor, Frozen Donor, Fresh Donor), By Infertility (Male, Female), By Application (Fertility Clinics, Hospitals, Others) By Region & Competition, 2020-2030F
Market Overview
The Global In-Vitro Fertilization Market was valued at USD 28.41 billion in 2024 and is projected to reach USD 40.87 billion by 2030, growing at a CAGR of 6.25% during the forecast period. Market growth is driven by rising infertility rates, technological advancements in assisted reproduction, and the increasing trend of delayed parenthood. In-vitro fertilization (IVF), a widely adopted assisted reproductive technology (ART), involves fertilizing an egg with sperm outside the body and transferring the embryo to the uterus. IVF has helped millions worldwide overcome infertility. Factors such as aging populations, lifestyle changes, and environmental stressors are contributing to rising infertility, pushing demand for ART solutions. Furthermore, advancements in IVF procedures—like improved embryo culture systems and personalized protocols—have increased success rates. Supportive government initiatives, expanded healthcare access, and growing public awareness are also making IVF more accessible, particularly in emerging economies, where a growing middle class and insurance coverage are further driving market adoption.
Key Market Drivers
Rising Infertility Rates Globally
The increasing global prevalence of infertility is a primary driver of the IVF market. According to the World Health Organization (WHO), one in six individuals faces infertility during their lifetime. Contributing factors include delayed parenthood, lifestyle habits, stress, obesity, and environmental pollutants. Fertility declines significantly in women after age 35, while male infertility is also rising due to reduced sperm quality. Governments and healthcare systems are acknowledging this challenge by supporting access to fertility treatments. In Europe, several countries offer full or partial reimbursement for IVF, while awareness initiatives by NGOs and health agencies are breaking social stigmas and encouraging treatment. Additionally, improved healthcare infrastructure and insurance access in developing nations are further enabling IVF adoption among a broader population base.
Key Market Challenges
High Cost of Treatment and Limited Accessibility
Despite growing demand, the high cost of IVF treatment remains a significant barrier, especially in low- and middle-income countries. IVF procedures often require substantial financial investment, with multiple cycles sometimes needed to achieve success. In many regions, fertility treatments are not fully covered by insurance, limiting access to those with financial means. For example, in the United States, IVF is frequently excluded from standard insurance plans, making it less accessible. In contrast, countries like Israel and certain parts of Europe provide public funding, resulting in higher uptake rates. The lack of universal coverage and inconsistent reimbursement structures continue to restrict broader adoption of IVF services.
Key Market Trends
Growing Acceptance of Fertility Preservation
Fertility preservation is emerging as a notable trend in the IVF market. Procedures such as egg, sperm, and embryo freezing are gaining popularity among individuals postponing parenthood for personal, career, or medical reasons. This trend is supported by healthcare providers and employers alike, with some companies now including fertility preservation as part of employee benefits. Additionally, fertility preservation is increasingly integrated into cancer care, with guidelines from medical bodies like ASCO recommending early discussions on fertility options before treatment. As public awareness and social acceptance of assisted reproduction continue to rise, the appeal of fertility preservation is expanding the IVF user base beyond traditional infertility patients, indicating strong long-term growth potential.
Key Market Players
Report Scope:
In this report, the Global In-Vitro Fertilization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global In-Vitro Fertilization Market.
Available Customizations:
Global In-Vitro Fertilization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
The Global In-Vitro Fertilization Market was valued at USD 28.41 billion in 2024 and is projected to reach USD 40.87 billion by 2030, growing at a CAGR of 6.25% during the forecast period. Market growth is driven by rising infertility rates, technological advancements in assisted reproduction, and the increasing trend of delayed parenthood. In-vitro fertilization (IVF), a widely adopted assisted reproductive technology (ART), involves fertilizing an egg with sperm outside the body and transferring the embryo to the uterus. IVF has helped millions worldwide overcome infertility. Factors such as aging populations, lifestyle changes, and environmental stressors are contributing to rising infertility, pushing demand for ART solutions. Furthermore, advancements in IVF procedures—like improved embryo culture systems and personalized protocols—have increased success rates. Supportive government initiatives, expanded healthcare access, and growing public awareness are also making IVF more accessible, particularly in emerging economies, where a growing middle class and insurance coverage are further driving market adoption.
Key Market Drivers
Rising Infertility Rates Globally
The increasing global prevalence of infertility is a primary driver of the IVF market. According to the World Health Organization (WHO), one in six individuals faces infertility during their lifetime. Contributing factors include delayed parenthood, lifestyle habits, stress, obesity, and environmental pollutants. Fertility declines significantly in women after age 35, while male infertility is also rising due to reduced sperm quality. Governments and healthcare systems are acknowledging this challenge by supporting access to fertility treatments. In Europe, several countries offer full or partial reimbursement for IVF, while awareness initiatives by NGOs and health agencies are breaking social stigmas and encouraging treatment. Additionally, improved healthcare infrastructure and insurance access in developing nations are further enabling IVF adoption among a broader population base.
Key Market Challenges
High Cost of Treatment and Limited Accessibility
Despite growing demand, the high cost of IVF treatment remains a significant barrier, especially in low- and middle-income countries. IVF procedures often require substantial financial investment, with multiple cycles sometimes needed to achieve success. In many regions, fertility treatments are not fully covered by insurance, limiting access to those with financial means. For example, in the United States, IVF is frequently excluded from standard insurance plans, making it less accessible. In contrast, countries like Israel and certain parts of Europe provide public funding, resulting in higher uptake rates. The lack of universal coverage and inconsistent reimbursement structures continue to restrict broader adoption of IVF services.
Key Market Trends
Growing Acceptance of Fertility Preservation
Fertility preservation is emerging as a notable trend in the IVF market. Procedures such as egg, sperm, and embryo freezing are gaining popularity among individuals postponing parenthood for personal, career, or medical reasons. This trend is supported by healthcare providers and employers alike, with some companies now including fertility preservation as part of employee benefits. Additionally, fertility preservation is increasingly integrated into cancer care, with guidelines from medical bodies like ASCO recommending early discussions on fertility options before treatment. As public awareness and social acceptance of assisted reproduction continue to rise, the appeal of fertility preservation is expanding the IVF user base beyond traditional infertility patients, indicating strong long-term growth potential.
Key Market Players
- The Fertility Center of Las Vegas
- Overlake Reproductive Health
- Gennet City Fertility
- Zita West Clinic
- Fertility Plus Clinic
- Nova IVF Centre and Fertility Clinic
- Bloom IVF Centre
- Progenesis Fertility Center
- Medicana IVF Center
- Medical Park Hospitals
- ART Fertility Clinics
Report Scope:
In this report, the Global In-Vitro Fertilization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- In-Vitro Fertilization Market, By Technique:
- ICSI IVF
- Non-ICSI/ Traditional IVF
- In-Vitro Fertilization Market, By Product:
- IVF Culture Media
- ICSI Machine
- IVF Incubators
- Cryo-System
- Others
- In-Vitro Fertilization Market, By Egg Donor:
- Frozen non-donor
- Fresh non-donor
- Frozen Donor
- Fresh Donor
- In-Vitro Fertilization Market, By Infertility:
- Male
- Female
- In-Vitro Fertilization Market, By Application:
- Fertility Clinics
- Hospitals
- Others
- In-Vitro Fertilization Market, By Region:
- North America
- United States
- Mexico
- Canada
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia-Pacific
- China
- India
- South Korea
- Japan
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global In-Vitro Fertilization Market.
Available Customizations:
Global In-Vitro Fertilization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. SERVICE OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL IN-VITRO FERTILIZATION MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technique (ICSI IVF v/s Non-ICSI/ Traditional IVF)
5.2.2. By Product (IVF Culture Media, ICSI Machine, IVF Incubators, Cryo-System, Others)
5.2.3. By Egg Donor (Frozen Non-donor, Fresh Non-donor, Frozen Donor, Fresh Donor)
5.2.4. By Infertility (Male v/s Female)
5.2.5. By Application (Fertility Clinics, Hospitals, Others)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Product Map
6. NORTH AMERICA IN-VITRO FERTILIZATION MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technique
6.2.2. By Product
6.2.3. By Egg Donor
6.2.4. By Infertility
6.2.5. By Application
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States In-Vitro Fertilization Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technique
6.3.1.2.2. By Product
6.3.1.2.3. By Egg Donor
6.3.1.2.4. By Infertility
6.3.1.2.5. By Application
6.3.2. Canada In-Vitro Fertilization Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technique
6.3.2.2.2. By Product
6.3.2.2.3. By Egg Donor
6.3.2.2.4. By Infertility
6.3.2.2.5. By Application
6.3.3. Mexico In-Vitro Fertilization Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technique
6.3.3.2.2. By Product
6.3.3.2.3. By Egg Donor
6.3.3.2.4. By Infertility
6.3.3.2.5. By Application
7. EUROPE IN-VITRO FERTILIZATION MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technique
7.2.2. By Product
7.2.3. By Egg Donor
7.2.4. By Infertility
7.2.5. By Application
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. France In-Vitro Fertilization Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technique
7.3.1.2.2. By Product
7.3.1.2.3. By Egg Donor
7.3.1.2.4. By Infertility
7.3.1.2.5. By Application
7.3.2. Germany In-Vitro Fertilization Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technique
7.3.2.2.2. By Product
7.3.2.2.3. By Egg Donor
7.3.2.2.4. By Infertility
7.3.2.2.5. By Application
7.3.3. United Kingdom In-Vitro Fertilization Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technique
7.3.3.2.2. By Product
7.3.3.2.3. By Egg Donor
7.3.3.2.4. By Infertility
7.3.3.2.5. By Application
7.3.4. Italy In-Vitro Fertilization Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Technique
7.3.4.2.2. By Product
7.3.4.2.3. By Egg Donor
7.3.4.2.4. By Infertility
7.3.4.2.5. By Application
7.3.5. Spain In-Vitro Fertilization Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Technique
7.3.5.2.2. By Product
7.3.5.2.3. By Egg Donor
7.3.5.2.4. By Infertility
7.3.5.2.5. By Application
8. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technique
8.2.2. By Product
8.2.3. By Egg Donor
8.2.4. By Infertility
8.2.5. By Application
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China In-Vitro Fertilization Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technique
8.3.1.2.2. By Product
8.3.1.2.3. By Egg Donor
8.3.1.2.4. By Infertility
8.3.1.2.5. By Application
8.3.2. India In-Vitro Fertilization Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technique
8.3.2.2.2. By Product
8.3.2.2.3. By Egg Donor
8.3.2.2.4. By Infertility
8.3.2.2.5. By Application
8.3.3. Japan In-Vitro Fertilization Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technique
8.3.3.2.2. By Product
8.3.3.2.3. By Egg Donor
8.3.3.2.4. By Infertility
8.3.3.2.5. By Application
8.3.4. South Korea In-Vitro Fertilization Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Technique
8.3.4.2.2. By Product
8.3.4.2.3. By Egg Donor
8.3.4.2.4. By Infertility
8.3.4.2.5. By Application
8.3.5. Australia In-Vitro Fertilization Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Technique
8.3.5.2.2. By Product
8.3.5.2.3. By Egg Donor
8.3.5.2.4. By Infertility
8.3.5.2.5. By Application
9. SOUTH AMERICA IN-VITRO FERTILIZATION MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technique
9.2.2. By Product
9.2.3. By Egg Donor
9.2.4. By Infertility
9.2.5. By Application
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil In-Vitro Fertilization Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technique
9.3.1.2.2. By Product
9.3.1.2.3. By Egg Donor
9.3.1.2.4. By Infertility
9.3.1.2.5. By Application
9.3.2. Argentina In-Vitro Fertilization Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technique
9.3.2.2.2. By Product
9.3.2.2.3. By Egg Donor
9.3.2.2.4. By Infertility
9.3.2.2.5. By Application
9.3.3. Colombia In-Vitro Fertilization Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technique
9.3.3.2.2. By Product
9.3.3.2.3. By Egg Donor
9.3.3.2.4. By Infertility
9.3.3.2.5. By Application
10. MIDDLE EAST AND AFRICA IN-VITRO FERTILIZATION MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technique
10.2.2. By Product
10.2.3. By Egg Donor
10.2.4. By Infertility
10.2.5. By Application
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa In-Vitro Fertilization Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Technique
10.3.1.2.2. By Product
10.3.1.2.3. By Egg Donor
10.3.1.2.4. By Infertility
10.3.1.2.5. By Application
10.3.2. Saudi Arabia In-Vitro Fertilization Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Technique
10.3.2.2.2. By Product
10.3.2.2.3. By Egg Donor
10.3.2.2.4. By Infertility
10.3.2.2.5. By Application
10.3.3. UAE In-Vitro Fertilization Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Technique
10.3.3.2.2. By Product
10.3.3.2.3. By Egg Donor
10.3.3.2.4. By Infertility
10.3.3.2.5. By Application
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. GLOBAL IN-VITRO FERTILIZATION MARKET: SWOT ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. The Fertility Center of Las Vegas
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Overlake Reproductive Health
15.3. Gennet City Fertility
15.4. Zita West Clinic
15.5. Fertility Plus Clinic
15.6. Nova IVF Centre and Fertility Clinic
15.7. Bloom IVF Centre
15.8. Progenesis Fertility Center
15.9. Medicana IVF Center
15.10. Medical Park Hospitals
15.11. ART Fertility Clinics
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL IN-VITRO FERTILIZATION MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technique (ICSI IVF v/s Non-ICSI/ Traditional IVF)
5.2.2. By Product (IVF Culture Media, ICSI Machine, IVF Incubators, Cryo-System, Others)
5.2.3. By Egg Donor (Frozen Non-donor, Fresh Non-donor, Frozen Donor, Fresh Donor)
5.2.4. By Infertility (Male v/s Female)
5.2.5. By Application (Fertility Clinics, Hospitals, Others)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Product Map
6. NORTH AMERICA IN-VITRO FERTILIZATION MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technique
6.2.2. By Product
6.2.3. By Egg Donor
6.2.4. By Infertility
6.2.5. By Application
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States In-Vitro Fertilization Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technique
6.3.1.2.2. By Product
6.3.1.2.3. By Egg Donor
6.3.1.2.4. By Infertility
6.3.1.2.5. By Application
6.3.2. Canada In-Vitro Fertilization Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technique
6.3.2.2.2. By Product
6.3.2.2.3. By Egg Donor
6.3.2.2.4. By Infertility
6.3.2.2.5. By Application
6.3.3. Mexico In-Vitro Fertilization Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technique
6.3.3.2.2. By Product
6.3.3.2.3. By Egg Donor
6.3.3.2.4. By Infertility
6.3.3.2.5. By Application
7. EUROPE IN-VITRO FERTILIZATION MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technique
7.2.2. By Product
7.2.3. By Egg Donor
7.2.4. By Infertility
7.2.5. By Application
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. France In-Vitro Fertilization Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technique
7.3.1.2.2. By Product
7.3.1.2.3. By Egg Donor
7.3.1.2.4. By Infertility
7.3.1.2.5. By Application
7.3.2. Germany In-Vitro Fertilization Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technique
7.3.2.2.2. By Product
7.3.2.2.3. By Egg Donor
7.3.2.2.4. By Infertility
7.3.2.2.5. By Application
7.3.3. United Kingdom In-Vitro Fertilization Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technique
7.3.3.2.2. By Product
7.3.3.2.3. By Egg Donor
7.3.3.2.4. By Infertility
7.3.3.2.5. By Application
7.3.4. Italy In-Vitro Fertilization Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Technique
7.3.4.2.2. By Product
7.3.4.2.3. By Egg Donor
7.3.4.2.4. By Infertility
7.3.4.2.5. By Application
7.3.5. Spain In-Vitro Fertilization Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Technique
7.3.5.2.2. By Product
7.3.5.2.3. By Egg Donor
7.3.5.2.4. By Infertility
7.3.5.2.5. By Application
8. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technique
8.2.2. By Product
8.2.3. By Egg Donor
8.2.4. By Infertility
8.2.5. By Application
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China In-Vitro Fertilization Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technique
8.3.1.2.2. By Product
8.3.1.2.3. By Egg Donor
8.3.1.2.4. By Infertility
8.3.1.2.5. By Application
8.3.2. India In-Vitro Fertilization Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technique
8.3.2.2.2. By Product
8.3.2.2.3. By Egg Donor
8.3.2.2.4. By Infertility
8.3.2.2.5. By Application
8.3.3. Japan In-Vitro Fertilization Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technique
8.3.3.2.2. By Product
8.3.3.2.3. By Egg Donor
8.3.3.2.4. By Infertility
8.3.3.2.5. By Application
8.3.4. South Korea In-Vitro Fertilization Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Technique
8.3.4.2.2. By Product
8.3.4.2.3. By Egg Donor
8.3.4.2.4. By Infertility
8.3.4.2.5. By Application
8.3.5. Australia In-Vitro Fertilization Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Technique
8.3.5.2.2. By Product
8.3.5.2.3. By Egg Donor
8.3.5.2.4. By Infertility
8.3.5.2.5. By Application
9. SOUTH AMERICA IN-VITRO FERTILIZATION MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technique
9.2.2. By Product
9.2.3. By Egg Donor
9.2.4. By Infertility
9.2.5. By Application
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil In-Vitro Fertilization Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technique
9.3.1.2.2. By Product
9.3.1.2.3. By Egg Donor
9.3.1.2.4. By Infertility
9.3.1.2.5. By Application
9.3.2. Argentina In-Vitro Fertilization Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technique
9.3.2.2.2. By Product
9.3.2.2.3. By Egg Donor
9.3.2.2.4. By Infertility
9.3.2.2.5. By Application
9.3.3. Colombia In-Vitro Fertilization Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technique
9.3.3.2.2. By Product
9.3.3.2.3. By Egg Donor
9.3.3.2.4. By Infertility
9.3.3.2.5. By Application
10. MIDDLE EAST AND AFRICA IN-VITRO FERTILIZATION MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technique
10.2.2. By Product
10.2.3. By Egg Donor
10.2.4. By Infertility
10.2.5. By Application
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa In-Vitro Fertilization Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Technique
10.3.1.2.2. By Product
10.3.1.2.3. By Egg Donor
10.3.1.2.4. By Infertility
10.3.1.2.5. By Application
10.3.2. Saudi Arabia In-Vitro Fertilization Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Technique
10.3.2.2.2. By Product
10.3.2.2.3. By Egg Donor
10.3.2.2.4. By Infertility
10.3.2.2.5. By Application
10.3.3. UAE In-Vitro Fertilization Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Technique
10.3.3.2.2. By Product
10.3.3.2.3. By Egg Donor
10.3.3.2.4. By Infertility
10.3.3.2.5. By Application
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. GLOBAL IN-VITRO FERTILIZATION MARKET: SWOT ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. The Fertility Center of Las Vegas
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Overlake Reproductive Health
15.3. Gennet City Fertility
15.4. Zita West Clinic
15.5. Fertility Plus Clinic
15.6. Nova IVF Centre and Fertility Clinic
15.7. Bloom IVF Centre
15.8. Progenesis Fertility Center
15.9. Medicana IVF Center
15.10. Medical Park Hospitals
15.11. ART Fertility Clinics
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
